U.S. Pharmacist

• An Overview of New Biologics for Migraine Prophylaxis Review what you need to know regarding the three calcitonin CGRP antagonists which were recently FDA approved for prophylactic treatment of migraine.
  U.S. Pharmacist, March 30, 2020
• Appropriate Use and Stewardship of Proton-Pump Inhibitors While proton-pump inhibitors are effective for a wide variety of conditions, they are not without risk, especially when used long-term. Review their appropriate and inappropriate use in this article.
  U.S. Pharmacist, January 31, 2020
• Alcohol Withdrawal in the Inpatient Setting This review explores a variety of pharmacologic options for treatment of alcohol withdrawal syndrome in hospitalized patients.
  U.S. Pharmacist, January 24, 2020
• Avoiding Drug-Induced Hypoglycemia in the Older Adult Many medications have the potential to induce hypoglycemia, especially in the older patient. Review the signs and symptoms of drug-induced hypoglycemia as well as the common culprits in this article.
  U.S. Pharmacist, January 10, 2020
• OTC Medication Use in Pregnancy and Breastfeeding Which over-the-counter medications are safe to use during pregnancy or the breastfeeding period?
  U.S. Pharmacist, November 22, 2019
• Testosterone Replacement Therapy: Controversy and Trends The use of testosterone replacement therapy remains controversial. What does the current literature tell us about risks and benefits of this treatment?
  U.S. Pharmacist, November 08, 2019
• Severe Asthma: An Update for 2019 This review focuses on the management of patients presenting with acute, poorly controlled asthma, highlighting therapeutic options for acute exacerbations and prevention.
  U.S. Pharmacist, September 05, 2019
• Overcoming Barriers to Statin Adherence Poor adherence can be a significant barrier to effective statin therapy. What steps can be taken to improve adherence and manage intolerance and other adverse effects?
  U.S. Pharmacist, July 26, 2019
• Anticoagulation in Pediatrics: DOACs on the Horizon DOACs have not yet been approved for pediatric use. This article reviews current studies and what you should know regarding selecting appropriate anticoagulation therapy for children.
  U.S. Pharmacist, July 02, 2019
• Updates in the Management of Clostridium difficile for Adults This article reviews recent guideline updates for the treatment of C. difficile infection, which reflect significant changes from previous recommendations.
  U.S. Pharmacist, June 18, 2019
• OTC Transdermal Analgesic Patches in Pain Management Review the use of over-the-counter transdermal pain patches in this article. Which types are most effective, and how should you counsel patients on their proper use?
  U.S. Pharmacist, May 22, 2019
• Management of Acute Ischemic Stroke: Guideline Updates This paper summarizes 2018 guidelines by the American Heart Association/American Stroke Association outlining optimal treatment for early management of patients with acute ischemic stroke.
  U.S. Pharmacist, April 22, 2019
• Crohn's Disease Treatment Update This article presents the American College of Gastroenterology's updated guidelines on managing Crohn's disease in adult patients.
  U.S. Pharmacist, March 22, 2019
• Alzheimer's Disease: Current and Potential New Treatments This paper reviews the pharmacological options which are currently available for treatment of Alzheimer disease, as well as potential new agents and approaches under investigation.
  U.S. Pharmacist, February 22, 2019
• Management of Nightmare Disorder in Adults Review the options for nonpharmacologic and pharmacologic treatment of adult nightmare disorder as presented in a 2018 position paper by the American Academy of Sleep Medicine.
  U.S. Pharmacist, January 07, 2019
• Applying Recent A1C Recommendations in Clinical Practice Three clinical guidelines were published in 2018 that address the use of A1C in the diagnosis and management of diabetes mellitus--but they don't all agree. Explore the controversy in this paper.
  U.S. Pharmacist, December 06, 2018
• Role of PARP Inhibitors in BRCA-Related Malignancies Review the pharmacology of PARP inhibitors and their use in BRCA-mutated malignancies including breast, ovarian, fallopian tube, and primary peritoneal cancers.
  U.S. Pharmacist, November 06, 2018
• Prostate Cancer Review This review summarizes current approaches to prostate cancer screening, diagnosis, and treatment. What recent advances have been made in characterizing disease risk and expanding therapeutic options?
  U.S. Pharmacist, October 23, 2018
• Managing Chronic and Acute COPD Exacerbations Review an updated pharmacotherapy treatment algorithm and new recommendations for the prevention and management of acute COPD exacerbations as presented in the latest GOLD guidelines.
  U.S. Pharmacist, October 08, 2018
• Updates in Pharmacotherapy for Melanoma This article reviews the latest new and emerging systemic therapies for advanced melanoma, including immunotherapy and targeted therapy.
  U.S. Pharmacist, September 07, 2018